GYREGyre Therapeutics, Inc.
$6.76-7.0% 1Y
$6.76
$5.5652 weeks$8.87
What is the market doing?
Watch
1 to watch, 2 without dataIn a downtrend (−4% vs 200-day). That is the only one of 3 checks this filer's data supports, so take it as a single data point rather than a settled answer.
TrendDowntrendderived · Oct 8, 2026
In a downtrend, below its 50- and 200-day averages. Price is −4% vs its 200-day average.
Where this answer is blind. Insider selling is often routine (taxes, diversification); only cluster buying is a strong tell.
How GYRE is trading
Gyre Therapeutics, Inc. is −7.0% over the past year while the S&P 500 is +18%: 25 points behind the market.
−7.0%
1-year return · S&P 500 +18%
- vs 200-day average
- −4.4%
vs 200-day average · below trend, but not far
- RSI (14)
- 31
RSI (14) · neutral
- Below its 52-week high
- 24%
Below its 52-week high
Details›
- Last close2026-10-08
- $6.76
- 1 monthS&P 500 +1.6%
- −2.7%
- 1 yearS&P 500 +18%
- −7.0%
- 5 yearsS&P 500 +86%
- −33%
- vs 50-day average$6.82
- −0.88%
- 52-week high
- $8.87
- 52-week low
- $5.56
- Annualised volatility
- 76%
- Insider buying, net, 6 monthsForms 3/4/5 to 2026-10-08
- −$870K
| Year | Return |
|---|---|
| 2026 (year to date) | −4.2% |
| 2025 | −42% |
| 2024 | −53% |
| 2023 | +422% |
| 2022 | +122% |
| 2021 | −86% |
| 2020 | −7.3% |
| 2019 | −14% |
| 2018 | −42% |
| 2017 | +40% |
| Month | Years | Positive | Average |
|---|---|---|---|
| Jan | 10 | 4 of 10 | −1.2% |
| Feb | 10 | 6 of 10 | +3.1% |
| Mar | 10 | 3 of 10 | −8.5% |
| Apr | 10 | 5 of 10 | +1.2% |
| May | 10 | 3 of 10 | +7.5% |
| Jun | 10 | 5 of 10 | +2.2% |
| Jul | 11 | 3 of 11 | −2.3% |
| Aug | 11 | 7 of 11 | +4.0% |
| Sep | 11 | 3 of 11 | −1.7% |
| Oct | 11 | 5 of 11 | −2.8% |
| Nov | 10 | 6 of 10 | +25% |
| Dec | 10 | 4 of 10 | +5.5% |
End-of-day closes from IEX; the S&P 500 comparison uses SPY over the same window. Prices are a reference point, not a basis for trading decisions.